Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

被引：0
|
作者：
Bosse, Tjalling
Nout, Remi A.
McAlpine, Jessica N.
McConechy, Melissa
Britton, Heidi
Ganesan, Raji
Steele, Jane C.
Harrison, Beth T.
Oliva, Esther
Matias-Guiu, Xavier
Gilks, Blake
Soslow, Robert
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ British Columbia, Vancouver, BC, Canada
[3] BC Canc Agcy, Vancouver, BC, Canada
[4] Birmingham Womens HS Fdn Trust, Birmingham, W Midlands, England
[5] Massachussets Gen Hosp, Boston, MA USA
[6] Hosp Arnau Vilanova, Lleida, Spain
[7] Hosp Univ Bellvitge, Lleida, Spain
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] McGill Univ, Montreal, PQ, Canada
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1113
引用
收藏
页码：277A / 277A
页数：1
相关论文
共 50 条
  • [21] Molecular Classification of Metastatic and Recurrent Endometrial Endometrioid Carcinoma
    Devereaux, Kelly
    Chow, Stephanie
    Steiner, David
    Peters-Schulze, Grace
    Ho, Chandler
    Suarez, Carlos
    Folkins, Ann
    Howitt, Brooke
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1041 - 1042
  • [22] Molecular Classification of Metastatic and Recurrent Endometrial Endometrioid Carcinoma
    Devereaux, Kelly
    Chow, Stephanie
    Steiner, David
    Peters-Schulze, Grace
    Ho, Chandler
    Suarez, Carlos
    Folkins, Ann
    Howitt, Brooke
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1041 - 1042
  • [23] Genomic Characterization of Vulvar (Pre) cancers Identifies Distinct Molecular Subtypes with Prognostic Significance
    Nooij, Linda S.
    ter Haar, Natalja T.
    Ruano, Dina
    Rakislova, Natalia
    van Wezel, Tom
    Smit, Vincent T. H. B. M.
    Trimbos, Baptist J. B. M. Z.
    Ordi, Jaume
    van Poelgeest, Mariette I. E.
    Bosse, Tjalling
    CLINICAL CANCER RESEARCH, 2017, 23 (22) : 6781 - 6789
  • [24] GENOMIC CHARACTERISATION OF VULVAR (PRE)CANCERS IDENTIFIES DISTINCT MOLECULAR SUBTYPES WITH PROGNOSTIC SIGNIFICANCE
    Nooij, L.
    ter Haar, N.
    Ruano, D.
    Rakislova, N.
    Smit, V.
    Trimbos, B.
    Ordi, J.
    van Poelgeest, M.
    Bosse, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1832 - 1832
  • [25] GENOMIC CHARACTERISATION OF VULVAR (PRE) CANCERS IDENTIFIES DISTINCT MOLECULAR SUBTYPES WITH PROGNOSTIC SIGNIFICANCE
    Nooij, L.
    ter Haar, N.
    Ruano, D.
    Rakislova, N.
    Smit, V.
    Trimbos, B.
    Ordi, J.
    van Poelgeest, M.
    Bosse, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 352 - 352
  • [26] Molecular genetic profiles of serous and endometrioid endometrial cancers, genes downregulated in endometrial cancers, and the role of epigenetics
    Risinger, JI
    Maxwell, GL
    Dainty, LA
    Chandramouli, GVR
    Berchuck, A
    Barrett, JC
    CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, 2003, : 245 - 251
  • [27] What is the role for additional prognostic markers in the framework of molecular classification in endometrial cancers
    Karnezis, A.
    Kommoss, S.
    Kommoss, F.
    Leung, S.
    Talhouk, A.
    Magrill, J.
    McConechy, M.
    Gilks, C. B.
    Huntsman, D.
    McAlpine, J. N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 62 - 62
  • [28] Molecular Signature of Aggressive Low Grade Endometrioid Endometrial Adenocarcinomas
    Sur, Monalisa
    Hyrcza, Martin
    Nirmalanantham, Priyatharsini
    Brett, Mary Anne
    Sundaravadanam, Yogi
    Sur, Ranjan
    Elit, Laurie
    Lytwyn, Alice
    LABORATORY INVESTIGATION, 2019, 99
  • [29] Molecular Signature of Aggressive Low Grade Endometrioid Endometrial Adenocarcinomas
    Sur, Monalisa
    Hyrcza, Martin
    Nirmalanantham, Priyatharsini
    Brett, Mary Anne
    Sundaravadanam, Yogi
    Sur, Ranjan
    Elit, Laurie
    Lytwyn, Alice
    MODERN PATHOLOGY, 2019, 32
  • [30] β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers
    Myers, Andrea
    Barry, William T.
    Hirsch, Michelle S.
    Matulonis, Ursula
    Lee, Larissa
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 426 - 427
12345